You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK (GenomeWeb) – The American Society of Clinical Oncology and precision medicine firm Tempus have agreed to work together in support of ASCO's Targeted Agent and Profiling Utilization (TAPUR) Study.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.